TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/16/2026
Back to search
Official data from USPTO
EXOTAC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
EXOTAC
ST13
US500000097106183Class
1, 5, 42
Filing
97106183
Registration
7459469
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
03/18/2026
Trademark type
Word
Nice classes
1, 5, 42
Filing date
11/03/2021
Registration date
07/30/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/30/2024
Last transaction
03/18/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
03
Owner location
Daejeon, KR
Examiner
DWYER, JOHN D
Law office
M70
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
ILIAS Biologics Inc.
Representatives
Janice Housey Litmus Law PLLC
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Biological preparationsother than for medical or veterinary purposes; biological preparation for use in cell cultures other than for medical or veterinary use; biological preparation for use in the manufacture of pharmaceuticals; biological preparations for use in experiments containing exosomes carrying the desired proteinother than for medical or veterinary use; biochemical preparations for gene recombination for scientific or laboratory purposes; biological tissue culturesother than for medical or veterinary purposes; cells for scientific or laboratory purposes; biological preparations for scientific or laboratory purposes other than for medical or veterinary use; diagnostic reagents for scientific or research use; diagnostic reagents for use in biological or genetic engineering for scientific or research use and medical laboratory use; reagents for scientific or medical research use; biological preparations for use in biotechnology industry and scienceother than for medical purpose; cell growth media for growing cells for use in scientific research; biochemicals for in vitro and in vivo scientific use; reagents for medical research; biological preparation containingexosomes for use in manufacture of cosmetics; protein for use in the manufacture of cosmetics; chemical preparations for use in the manufacture of cosmetics; chemical additives for use in the manufacture of cosmetics; proteins for the food industry
Class 5
Biological preparations for medical or veterinary purposes for the treatment of cancermetabolic diseasesinflammatory diseasesgenetic diseasesinfectious diseasescardiovascular diseasesrespiratory diseasesneurological diseasesauto-immune diseasesfibrosis diseasesallergiesskin diseasesendocrine diseasesgastrointestinal diseaseshematologic diseasesdiseases and disorders of the immune systemophthalmic diseaseskidney diseasesurinary diseases; biochemical preparations for medical or veterinary purposes for the treatment of cancermetabolic diseasesinflammatory diseasesgenetic diseasesinfectious diseasescardiovascular diseasesrespiratory diseasesneurological diseasesauto-immune diseasesfibrosis diseasesallergiesskin diseasesendocrine diseasesgastrointestinal diseaseshematologic diseasesdiseases and disorders of the immune systemophthalmic diseaseskidney diseasesurinary diseases; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceuticals featuring drug delivery systempharmaceutical preparations for the treatment of cancermetabolic diseasesinflammatory diseasesgenetic diseasesinfectious diseasescardiovascular diseasesrespiratory diseasesneurological diseasesauto-immune diseasesfibrosis diseasesallergiesskin diseasesendocrine diseasesgastrointestinal diseaseshematologic diseasesdiseases and disorders of the immune systemophthalmic diseaseskidney diseasesurinary diseases; preparations for intracellular drug deliverydrug delivery agents in the form of capsulestabletspillspowdersliquidssuspensionsinjectionscreamsemulsionsgelslinimentslotionsointmentspathessolutionssyrupsaerosolsgranulesimplantsinhalantspellets that facilitate the delivery of pharmaceutical preparations; pharmaceuticals for the treatment of immune system disease; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of cellular diseases; chemico-pharmaceutical preparations for the treatment of cancermetabolic diseasesinflammatory diseasesgenetic diseasesinfectious diseasescardiovascular diseasesrespiratory diseasesneurological diseasesauto-immune diseasesfibrosis diseasesallergiesskin diseasesendocrine diseasesgastrointestinal diseaseshematologic diseasesdiseases and disorders of the immune systemophthalmic diseaseskidney diseasesurinary diseases; protein preparationsprotein supplements; biotechnological preparations for medical purposes for treatment of cancermetabolic diseasesinflammatory diseasesgenetic diseasesinfectious diseasescardiovascular diseasesrespiratory diseasesneurological diseasesauto-immune diseasesfibrosis diseasesallergiesskin diseasesendocrine diseasesgastrointestinal diseaseshematologic diseasesdiseases and disorders of the immune systemophthalmic diseaseskidney diseasesurinary diseases; reagents for medical use; pharmaceuticals for human purposes for the treatment of cancermetabolic diseasesinflammatory diseasesgenetic diseasesinfectious diseasescardiovascular diseasesrespiratory diseasesneurological diseasesauto-immune diseasesfibrosis diseasesallergiesskin diseasesendocrine diseasesgastrointestinal diseaseshematologic diseasesdiseases and disorders of the immune systemophthalmic diseaseskidney diseasesurinary diseases; biochemical pharmaceuticals for the treatment of cancermetabolic diseasesinflammatory diseasesgenetic diseasesinfectious diseasescardiovascular diseasesrespiratory diseasesneurological diseasesauto-immune diseasesfibrosis diseasesallergiesskin diseasesendocrine diseasesgastrointestinal diseaseshematologic diseasesdiseases and disorders of the immune systemophthalmic diseaseskidney diseasesurinary diseases; biological tissue cultures for medical purposes; diagnostic reagents for medical use; pharmaceuticals for the treatment of cancermetabolic diseasesinflammatory diseasesgenetic diseasesinfectious diseasescardiovascular diseasesrespiratory diseasesneurological diseasesauto-immune diseasesfibrosis diseasesallergiesskin diseasesendocrine diseasesgastrointestinal diseaseshematologic diseasesdiseases and disorders of the immune systemophthalmic diseaseskidney diseasesurinary diseases
Class 42
Research and development of technology for biotechnology; development of pharmaceutical preparations and medicines; development of cell therapy products; research and development of new pharmaceuticals; medical research and product development services; research and development of vaccines and medicines; product development in the field of biologics; research of biologicsscientific study and research in the field of biologics; laboratory research in the field of biology; industrial research in the field of biomedical engineering; technological research in the field of cell biology; scientific research in the field of pharmaceuticals; biotechnology research; biological research services; research for medical products; research in the field of chemistry; drug discovery services; biomedical research services; pharmaceutical drug development services
Publications
History of USPTO decisions and trademark events.
32 publications found
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
03/16/2026
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
03/16/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/16/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/16/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/16/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/16/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/30/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
07/30/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/14/2024
PUBO
PUBLISHED FOR OPPOSITION
05/14/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/24/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/11/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/11/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/11/2024
ALIE
ASSIGNED TO LIE
04/09/2024
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
11/18/2023
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
09/11/2023
GNSI
INQUIRY TO SUSPENSION E-MAILED
09/11/2023
CNSI
SUSPENSION INQUIRY WRITTEN
09/11/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
03/14/2023
GNSL
LETTER OF SUSPENSION E-MAILED
03/14/2023
CNSL
SUSPENSION LETTER WRITTEN
03/14/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/20/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/18/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/18/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/21/2022
GNRT
NON-FINAL ACTION E-MAILED
08/21/2022
CNRT
NON-FINAL ACTION WRITTEN
08/21/2022
DOCK
ASSIGNED TO EXAMINER
08/13/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/13/2021
NWAP
NEW APPLICATION ENTERED
11/06/2021
Continuous trademark protection
Get notified about every new filing that threatens EXOTAC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.